Concepedia

Author

Indra Neil Guha

University of NottinghamORCID

Also Known As

Guha, I, Guha, I., N., Guha, IN, I GUHA, I Guha, I N Guha, I Nehil Guha, I Neil Guha, I. Guha, I. N. Guha

221

Publications

9.4K

Citations

44

H-Index

83

Concepts

All Affiliations

University of NottinghamNottingham University Hospitals NHS TrustNottingham Biomedical Research CentreNIHR Nottingham Digestive Diseases Biomedical Research UnitNational Institute for Health Research
IN

About

Indra Neil Guha is an author at University of Nottingham specializing in medicine, hepatology, and pathology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

17

20

2.7K

2

Epidemiology

8

8

842

3

Health Sciences

7

7

2K

4

Public Health

5

5

372

5

Diabetes

1

1

71

Indra Neil Guha

×

73

Publications

7.4K

Citations

36

H-Index

YearCitations

Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease

Peter Eddowes, M. Sasso, Michael Allison,

Gastroenterology

2019

1.3K

Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European Liver Fibrosis Panel and exploring simple markers

Indra Neil Guha, Julie Parkes, Paul Roderick,

Hepatology

2007

732

FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study

Philip N. Newsome, M. Sasso, Jonathan J Deeks,

˜The œLancet. Gastroenterology & hepatology

2020

729

MAIT cells are activated during human viral infections

Bonnie van Wilgenburg, Iris Scherwitzl, Edward Hutchinson,

Nature Communications

2016

509

aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis

Rong Fan, George Papatheodoridis, Jian Sun,

Journal of Hepatology

2020

323

Low Accuracy of FIB-4 and NAFLD Fibrosis Scores for Screening for Liver Fibrosis in the Population

Isabel Graupera, Maja Thiele, Miquel Serra‐Burriel,

Clinical Gastroenterology and Hepatology

2021

254

ADAPT: An Algorithm Incorporating PRO‐C3 Accurately Identifies Patients With NAFLD and Advanced Fibrosis

Samuel J. Daniels, Diana Julie Leeming, Mohammed Eslam,

Hepatology

2018

247

Screening for liver fibrosis in the general population: a call for action

Pere Ginès, Isabel Graupera, Frank Lammert,

˜The œLancet. Gastroenterology & hepatology

2016

177

Enhanced Liver Fibrosis (ELF) test accurately identifies liver fibrosis in patients with chronic hepatitis C

Julie Parkes, Indra Neil Guha, Paul Roderick,

Journal of Viral Hepatitis

2010

172

Consistent beneficial effects of killer cell immunoglobulin‐like receptor 2DL3 and group 1 human leukocyte antigen‐C following exposure to hepatitis C virus†

Susanne Knapp, U. Warshow, Doha Hegazy,

Hepatology

2009

156

Page 1